Name | 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine |
---|---|
Synonyms |
2-Pyrimidinamine, 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)-
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)pyrimidin-2-amine 5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-4-(trifluoromethyl)-2-pyrimidinamine |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 403.8±55.0 °C at 760 mmHg |
Molecular Formula | C11H15BF3N3O2 |
Molecular Weight | 289.062 |
Flash Point | 198.0±31.5 °C |
Exact Mass | 289.120941 |
PSA | 70.26000 |
LogP | 1.95800 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.476 |
Storage condition | 2-8°C |
Hazard Codes | Xi |
---|---|
HS Code | 2934999090 |
~% 944401-58-5 |
Literature: WO2008/98058 A1, ; Page/Page column 63-64 ; WO 2008/098058 A1 |
~40% 944401-58-5 |
Literature: NOVARTIS AG; Fairhurst, Robin Alec; Furet, Pascal; Kalthoff, Frank Stephan; Lerchner, Andreas; Rueeger, Heinrich Patent: US2014/135330 A1, 2014 ; Location in patent: Paragraph 0218 ; |
~% 944401-58-5 |
Literature: US2013/225574 A1, ; |
Precursor 3 | |
---|---|
DownStream 0 |
HS Code | 2934999090 |
---|---|
Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |